{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:23:05Z","timestamp":1780586585916,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["VR-523-2014-2048"],"award-info":[{"award-number":["VR-523-2014-2048"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jneuroim.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T23:04:38Z","timestamp":1538780678000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Circulating microRNA plasma profile in MuSK+ myasthenia gravis"],"prefix":"10.1016","volume":"325","author":[{"given":"Liis","family":"Sabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern C.","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice M.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James F.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Hobson-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.10.003_bb0005","first-page":"6511","article-title":"MiRNA-210: a Current Overview","volume":"37","author":"Bavelloni","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0015","article-title":"Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0025","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/s41598-018-22844-2","article-title":"Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry","volume":"8","author":"Feichtinger","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0030","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3892\/mmr.2015.3879","article-title":"Profiling circulating microRNAs in maternal serum and plasma","volume":"12","author":"Ge","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0035","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0045","article-title":"A Comprehensive Analysis of miRNA\/isomiR Expression with Gender Difference","volume":"11","author":"Guo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0060","doi-asserted-by":"crossref","unstructured":"Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. 2000 Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thorac. Surg. 70: 327\u2013334.","DOI":"10.1016\/S0003-4975(00)01595-2"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","article-title":"Biomarker development for myasthenia gravis","volume":"1275","author":"Kaminski","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR","volume":"17","author":"Marabita","year":"2016","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2013.12.007","article-title":"T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients","volume":"52","author":"Marino","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","article-title":"Analysis of circulating microRNA: preanalytical and analytical challenges","volume":"57","author":"McDonald","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3988\/jcn.2009.5.2.53","article-title":"Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status","volume":"5","author":"Oh","year":"2009","journal-title":"J Clin Neurol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.21191","article-title":"Racial differences in myasthenia gravis in Alabama","volume":"39","author":"Oh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.13510","article-title":"Circulating microRNAs as potential biomarkers in myasthenia gravis patients","volume":"1412","author":"Punga","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2016.01.003","article-title":"Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis","volume":"292","author":"Punga","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2018.05.003","article-title":"Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis","volume":"321","author":"Sabre","year":"2018","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0130","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2042-6410-5-3","article-title":"Influence of sex differences on microRNA gene regulation in disease","volume":"5","author":"Sharma","year":"2014","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/b03fbc42-8f70-4873-9cce-854e48249a13","article-title":"MicroRNA-based promotion of human neuronal differentiation and subtype specification","volume":"8","author":"Stappert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0150","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fncel.2014.00156","article-title":"Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy","volume":"8","author":"Vallelunga","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0155","article-title":"Comparing the MicroRNA spectrum between serum and plasma","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.10.003_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/01616412.2016.1250857","article-title":"Identification of the miRNA-mRNA regulatory network in multiple sclerosis","volume":"39","author":"Yang","year":"2017","journal-title":"Neurol. Res."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:32:59Z","timestamp":1759048379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818303837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"alternative-id":["S0165572818303837"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.10.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNA plasma profile in MuSK+ myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}